iGUIDE System Product Usage: The intended use of the device is the control of accurate patien...

FDA Device Recall #Z-1807-2014 — Class II — May 29, 2014

Recall Summary

Recall Number Z-1807-2014
Classification Class II — Moderate risk
Date Initiated May 29, 2014
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Elekta, Inc.
Location Atlanta, GA
Product Type Devices
Quantity 224

Product Description

iGUIDE System Product Usage: The intended use of the device is the control of accurate patient positioning with the assistance of a 30 Tracking System in a radiotherapy environment.

Reason for Recall

A bug in the software prevents the iGUIDE software from logging off.

Distribution Pattern

Worldwide Distribution - USA (nationwide) in the states of AZ, CA, CT, HI, IL, IA, KY, MD, MA, MI, MO, NH, NJ, NC, ND, OH, OK, OR, PA, TX, VA, WA, WI, and the countries of Algeria, Australia, Austria, Brazil, Canada, China, Colombia, Denmark, Finland, France, Germany, Hong Kong, India, Italy, Japan, Kazakhstan, Mexico, Netherlands, New Zealand, Peru, Poland, Russia, Saudi Arabia, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, United Kingdom and Vietnam

Lot / Code Information

Software Versions 2.0.0, 2.0.1 and 2.0.2

Other Recalls from Elekta, Inc.

Recall # Classification Product Date
Z-1581-2026 Class II Brand Name: Leksell Gamma Knife Product Descri... Feb 18, 2026
Z-1164-2026 Class II Brand Name: Elekta Medical Linear Accelerator ... Dec 14, 2025
Z-1339-2026 Class II Brand Name: Leksell GammaPlan Product Name: Ra... Dec 12, 2025
Z-1340-2026 Class II Brand Name: Leksell GammaPlan Product Name: Ra... Dec 12, 2025
Z-1078-2026 Class II MOSAIQ Oncology Information System with Particl... Dec 10, 2025

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.